Antibiotic use in neonatal sepsis

Turkish Journal of Pediatrics

Volumn 40, Issue 1, 1998, Pages 17-33

  Yurdakök, Murat ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Antibiotic therapy; Newborn infant; Sepsis

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPICILLIN; AZLOCILLIN; AZTREONAM; BETA LACTAM ANTIBIOTIC; CARBAPENEM DERIVATIVE; CEFAMANDOLE; CEFOPERAZONE; CEFOTAXIME; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; CILASTATIN; CIPROFLOXACIN; IMIPENEM; ISEPAMICIN; LATAMOXEF; METICILLIN; NAFCILLIN; NETILMICIN; OXACILLIN; PENICILLIN DERIVATIVE; PENICILLIN G; PIPERACILLIN; PSEUDOMONIC ACID; QUINOLINE DERIVED ANTIINFECTIVE AGENT; UNINDEXED DRUG; UREIDOPENICILLIN; VANCOMYCIN; VITAMIN K GROUP;

ANTIBIOTIC THERAPY; BACTERIUM CULTURE; BLEEDING DISORDER; DRUG MIXTURE; ENTEROBACTER INFECTION; GRAM NEGATIVE INFECTION; HOSPITAL INFECTION; HUMAN; HYPERBILIRUBINEMIA; KERNICTERUS; LISTERIA MONOCYTOGENES; NEPHROTOXICITY; NEUROTOXICITY; NEWBORN SEPSIS; OTOTOXICITY; PREMATURITY; REVIEW; STAPHYLOCOCCUS INFECTION; STREPTOCOCCUS AGALACTIAE;

ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; DRUG RESISTANCE, MICROBIAL; HUMANS; INFANT, NEWBORN; INFECTION CONTROL; MICROBIAL SENSITIVITY TESTS; RISK FACTORS; SEPSIS; TIME FACTORS;

EID: 0031888354     PISSN: 00414301     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (72)

1. St. Gerne III JW, Polin RA. Prevention and treatment of neonatal sepsis. In: Spitzer AR (ed). Intensive Care of the Fetus and Neonate (Chapter 76). St. Louis: Mosby-Year Book, Inc; 1996.
2. th ed) (Chapter 35/2). St. Louis: Mosby-Year Book Inc; 1992.
3. rd ed) (Chapter 18). Philadelphia: WB Saunders; 1990: 601-656.
4. Greenough A, Osborne J, Sutherland S (eds). Congenital, Perinatal and Neonatal Infections. Edinburgh: Churchill Livingstone; 1992.
5. Bradley JS. Management of neonates with suspected sepsis. Pediatr Infect Dis J 1991; 10: 343-345.
6. Powell KR. Antimicrobial therapy for suspected sepsis in infants less than three months of age. Pediatr Infect Dis J 1992; 11: 143-145.
7. Weisman LE. Advances in the treatment of neonatal sepsis and meningitis. Isr J Med Sci 1994; 30: 455-458.
8. LiPuma JJ, Stull TL. Antibacterial agents in pediatrics. Infect Dis Clin North Am 1995; 9: 561-574.
9. Sotiropoulos SV. Antibiotic choices: the critical first hour. Pediatr Ann 1996; 25: 345-350.
10. Yancey MK, Duff P, Kubilis P, Clark P, Frentzen BH. Risk factors for neonatal sepsis. Obstet Gynecol 1996; 87: 188-194.
11. Stoll BJ, Gordon T, Korones SB, et al. Early-onset sepsis in very low birth weight neonates: a report from the National Institute of Child Health and Human Development Neonatal Research Network. J Pediatr 1996; 129: 72-80.
12. Heimler R, Nelin LD, Billmanh DO, Sasidharan P. Identification of sepsis in neonates following maternal antibiotic therapy. Clin Pediatr (Phila) 1995; 34: 133-137.
13. Singhal KK, La Gamma EF. Management of 168 neonates weighing more than 2000 g receiving intrapartum chemoprophylaxis for chorioamnionitis. Evaluation of an early discharge strategy. Arch Pediatr Adolesc Med 1996; 150: 158-163.
14. Hall MA, Beech RC, Seal DV. The use of cefotaxime for treating suspected neonatal sepsis: 2 years' experience. J Hosp Infect 1986; 8: 57-63.
15. Hall MA, Ducker DA, Lowes JA, et al. A randomized prospective comparison of cefotaxime versus netilmicin/penicillin for treatment of suspected neonatal sepsis. Drugs 1988; 35 (Suppl): 169-177.
16. de Louvois J, Dagan R, Tessin J. A comparison of ceftazidime and aminoglycoside based regimens as empirical treatment in 1316 cases of suspected sepsis in the newborn. European Society for Paediatric Infectious Diseases-Neonatal Sepsis Study Group. Eur J Pediatr 1992; 151: 876-884.
17. Van Reempts PJ, Van Overmeire B, Mahieu LM, Vanacker KJ. Clinical experience with ceftriaxone treatment in the neonate. Chemotherapy 1995; 41: 316-322.
18. Modi N, Damjanovic V, Cooke RW. Outbreak of cephalosporin resistant Enterobacter cloacae infection in a neonatal intensive care unit. Arch Dis Child 1987; 62: 148-151.
19. Bryan CS, John JF Jr, Pai MS, Austin TL. Gentamicin vs cefotaxime for therapy of neonatal sepsis. Relationship to drug resistance. Am J Dis Child 1985; 139: 1086-1089.
20. Murray BE. New aspects of antimicrobial resistance and the resulting therapeutic dilemmas. J Infect Dis 1991; 163: 1184-1194.
21. Wiese G. Treatment of neonatal sepsis with ceftriaxone/gentamicin and with azlocillin/gentamicin: a clinical comparison of efficacy and tolerability. Chemotherapy 1988; 34: 158-163.
22. Burns JL. Mechanisms of bacterial resistance. Pediatr Clin North Am 1995; 42: 497-507.
23. Simon C, Schröder H, Beyer C, Zerbst T. Neonatal sepsis in an intensive care unit and results of treatment. Infection 1991; 19: 146-149.
24. Gilman Gai Rall TN, Nies AS, Taylor P (eds). Goodman and Gilman's Pharmacological Basis of Therapeutics. New York: Pergamon Press; 1990.
25. Goldfarb J. New antimicrobial agents. Pediatr Clin North Am 1995; 42: 717-735.
26. Shulman ST, Yogev R. Treatment of pediatric infections with amikacin as first-line aminoglycoside. Am J Med 1985; 79: 43-50.
27. Hellinger WC, Brewer NS. Imipenem. Mayo Clin Proc 1991; 66: 1074-1081.
28. Blumer JL. Carbapenems in paediatrics. Scand J Infect Dis 1995; 96(Suppl): 38-44.
29. Umana MA, Odio CM, Castro E, Salas JL, McCracken GH Jr. Evaluation of aztreonam and ampicillin vs. amikacin and ampicillin for treatment of neonatal bacterial infections. Pediatr Infect Dis J 1990; 9: 175-180.
30. Sklavunu-Tsurutsoglu S, Gatzola-Karaveli M, Hatziioannidis K, Tsurutsoglu G. Efficacy of aztreonam in the treatment of neonatal sepsis. Rev Infect Dis 1991; 13 (Suppl): S591-S593.
31. Scaglione F, Vigano A, Colucci R, et al. Pharmacokinetics of isepamicin in paediatric patients. J Chemother 1995; 7 (Suppl): 63-69.
32. Vigano A, Principi N. A randomized comparison of isepamicin and amikacin in the treatment of bacterial infections in paediatric patients. J Chemother 1995; 7 (Suppl): 95-101.
33. Khan DM, Bhutta ZA. Ciprofloxacin in multi-resistant infections in childhood: an audit. JPMA J Pak Med Assoc 1995; 45: 147-150.
34. Linseman DA, Hampton LA, Branstetter DG. Quinolone-induced arthropathy in the neonatal mouse. Morphological analysis of articular lesions produced by pipemidic acid and Ciprofloxacin. Fundam Appl Toxicol 1995; 28: 59-64.
35. Schaad UB. Use of the new quinolones in pediatrics. Isr J Med Sci 1994; 30: 463-468.
36. Rice LB, Shales DM. Vancomycin resistance in the enterococcus. Relevance in pediatrics. Pediatr Clin North Am 1995; 42: 601-618.
37. Shay DK, Goldmann DA, Jarvis WR. Reducing the spread of antimicrobial-resistant microorganisms. Control of vancomycin-resistant Enterococci. Pediatr Clin North Am 1995; 42: 703-716.
38. McNeeley DF, Saint-Louis F, Noel GJ. Neonatal enterococcal bacteremia: an increasingly frequent event with potentially untreatable pathogens. Pediatr Infect Dis J 1996; 15: 800-805.
39. Salzman MB, Rubin LG. Intravenous catheter-related infections. Adv Pediatr Infect Dis 1995; 10: 337-368.
40. Moreira BM, Daum RS. Antimicrobial resistance in staphylococci. Pediatr Clin North Am 1995; 42: 619-648.
41. Chambers HF. Methicillin-resistant staphylococci. Clin Microbiol Rev 1988; 1: 173-186.
42. Moller JC, Nelskamp I, Jensen R, Gatermann S, Iven H, Gortner L. Teicoplanin pharmacology in prophylaxis for coagulase-negative staphylococcal sepsis of very low birthweight infants. Acta Paediatr 1996; 85: 638-639.
43. Cercenado E, Garcia-Leoni ME, Diaz MD, et al. Emergence of teicoplanin-resistant coagulase-negative staphylococci. J Clin Microbiol 1996; 34: 1765-1768.
44. Neumeister B, Kastner S, Conrad S, Klotz G, Bartmann P. Characterization of coagulase-negative staphylococci causing nosocomial infections in preterm infants. Eur J Clin Microbiol Infect Dis 1995; 14: 856-863.
45. Isaacs D, Wilkinson AR, Moxon ER. Duration of antibiotic courses for neonates. Arch Dis Child 1987; 62: 727-748.
46. Sato Y. Pharmacokinetics of antibiotics in neonates. Acta Paediatr Jpn 1997; 39: 124-131.
47. Paap CM, Nahata MC. Clinical pharmacokinetics of antibacterial drugs in neonates. Clin Pharmacokinet 1990; 19: 280-318.
48. Van Reempts PJ, Van Overmeire B, Mahieu LM, Vanacker KJ. Clinical experience with ceftriaxone treatment in the neonate. Chemotherapy 1995; 41: 316-322.
49. Qadsworth SJ, Suh B. In vitro displacement of bilirubin by antibiotics and 2-hydroxybenzoylglycine in newborns. Antimicrob Agents' Chemother 1988; 32: 1571-1575.
50. Adriaanse AH, Lagendijk I, Muytjens HL, Nijhuis JG, Kollee LA. Neonatal early onset group B streptococcal infection. A nine-year retrospective study in a tertiary care hospital. J Perinat Med 1996; 24: 531-538.
51. Committee on Infectious Diseases and Committee on Fetus and Newborn of American Academy of Pediatrics. Guidelines for prevention of group B streptococcal (GBS) infection by chemoprophylaxis. Pediatrics 1992; 90: 775-778.
52. Gilbert GL, Isaacs D, Burgess MA, et al. Prevention of neonatal group B streptococcal sepsis: is routine antenatal screening appropriate. Aust NZ J Obstet Gynecol 1995; 35: 120-126.
53. Regan JA, Klebanoff MA, Nugent RP, et al. Colonization with group B streptococci in pregnancy and adverse outcome. VIP Study Group. Am J Obstet Gynecol 1996; 174: 1354-1360.
54. Garland SM, Kelly N. Early-onset neonatal group B streptococcal sepsis: economics of various prevention strategies. Med J Aust 1995; 162: 413-417.
55. Mercer BM, Ramsey RD, Sibai BM. Prenatal screening for group B Streptococcus. I. Impact of antepartum screening and prophylaxis on neonatal care. Am J Obstet Gynecol 1995; 173: 842-846.
56. Rouse DJ, Goldenberg RL, Cliver SP, Cutter GR, Mennemeyer STD, Fargason CA Jr. Strategies for the prevention of early-onset neonatal group B streptococcal sepsis: a decision analysis. Obstet Gynecol 1994; 83: 483-494.
57. Philipson EH, Herson VC. Intrapartum chemoprophylaxis for group B streptococcus infection to prevent neonatal disease: who should be treated? Am J Perinatol 1996; 13: 487-490.
58. Schuchat A. Group B streptococcal disease in newborns: a global perspective on prevention. Biomed Pharmacother 1995; 49: 19-25.
59. Ariaanse AH, Kollée LA, Muytjens HL, Nijhuis JG, de Haan AF, Eskes TK. Randomized study of vaginal chlorhexidine disinfection during labor to prevent vertical transmission of group B streptococci. Eur J Obstet Gynecol Reprod Biol 1995; 61: 135-141.
60. Averbuch B, Mazor M, Shoham-Vardi I, et al. Intra-uterine infection in women with preterm premature rupture of membranes: maternal and neonatal characteristics. Eur J Obstet Gynecol Reprod Biol 1995; 62: 25-29.
61. Newton ER. Chorioamnionitis and intraamniotic infection. Clin Obstet Gynecol 1993; 36: 795-808.
62. Lewis DF, Fontenot MT, Brooks GG, Wise R, Perkins MB, Heymann AR. Latency period after preterm premature rupture of membranes: a comparison of ampicillin with and without sulbactam. Obstet Gynecol 1995; 86: 392-395.
63. Mercer BM, Arheart KL. Antimicrobial therapy in expectant management of preterm premature rupture of the membranes. Lancet 1995; 346: 1271-1279.
64. Egarter C, Leitich H, Karas H, et al. Antibiotic treatment in preterm premature rupture of membranes and neonatal morbidity: a metaanalysis. Am J Obstet Gynecol 1996; 174: 589-597.
65. Romero R, Sibai B, Caritis S, et al. Antibiotic treatment of preterm labor with intact membranes: a multicenter, randomized, double-blinded, placebo-controlled trial. Am J Obstet Gynecol 1993; 169: 764-774.
66. Under N, Ohel G, Gazit G, Keidar D, Tamir I, Reichman B. Neonatal sepsis after prolonged premature rupture of membranes. J Perinatol 1995; 15: 36-38.
67. Krishnan L, Nasruddin K, Prabhakar P, Bhaskaranand N. Routine antibiotic cover for newborns intubated for aspirating meconium: is it necessary? Indian Pediatr 1995; 32: 529-531.
68. Paynen NR, Schilling CG, Steinberg S. Selecting antibiotics for nosocomial bacterial infections in patients requiring neonatal intensive care. Neonatal Netw 1994; 13: 41-51.
69. Landers S, Moise AA, Fraley JK, Smith EO, Baker CJ. Factors associated with umbilical catheter-related sepsis in neonates. Am J Dis Child 1991; 145: 675-680.
70. harms K, Herting E, Kron M, Schiffmann H, Schulz-Ehlbeck H. Randomized, controlled trial of amoxicillin prophylaxis for prevention of catheter-related infections in newborn infants with central venous silicone elastomer catheters. J Pediatr 1995; 127: 615-619.
71. Zakrzewska-Bode A, Muytjens HL, Liem KD, Hoogkamp-Korstanje JA. Mupirocin resistance in coagulase-negative staphylococci, after topical prophylaxis for the reduction of colonization of central venous catheters. J Hosp Infect 1995; 31: 189-193.
72. Toltzis P, Blumer JL. Antibiotic-resistant gram-negative bacteria in the critical care setting. Pediatr Clin North Am 1995; 42: 687-702.